| Bioactivities of chalcones DW Elias, MA Beazely, NM Kandepu Current medicinal chemistry 6 (12), 1125, 1999 | 922 | 1999 |
| Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus RJ Thompson, MF Jackson, ME Olah, RL Rungta, DJ Hines, MA Beazely, ... Science 322 (5907), 1555-1559, 2008 | 407 | 2008 |
| Hippocampal long-term synaptic plasticity and signal amplification of NMDA receptors JF MacDonald, MF Jackson, MA Beazely Critical Reviews™ in Neurobiology 18 (1-2), 2006 | 227 | 2006 |
| Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires Gαq, protein kinase C, and activation of Src DS Macdonald, M Weerapura, MA Beazely, L Martin, W Czerwinski, ... Journal of Neuroscience 25 (49), 11374-11384, 2005 | 149 | 2005 |
| Regulatory properties of adenylate cyclases type 5 and 6: A progress report MA Beazely, VJ Watts European journal of pharmacology 535 (1-3), 1-12, 2006 | 111 | 2006 |
| G protein-coupled receptors control NMDARs and metaplasticity in the hippocampus JF MacDonald, MF Jackson, MA Beazely Biochimica et Biophysica Acta (BBA)-Biomembranes 1768 (4), 941-951, 2007 | 107 | 2007 |
| Postsynaptic clustering and activation of Pyk2 by PSD-95 JA Bartos, JD Ulrich, H Li, MA Beazely, Y Chen, JF MacDonald, JW Hell Journal of Neuroscience 30 (2), 449-463, 2010 | 96 | 2010 |
| Cytotoxic 2, 6-bis (arylidene) cyclohexanones and related compounds JR Dimmock, P Kumar, AJ Nazarali, NL Motaganahalli, TP Kowalchuk, ... European journal of medicinal chemistry 35 (11), 967-977, 2000 | 92 | 2000 |
| Development and evaluation of multifunctional agents for potential treatment of Alzheimer’s disease: application to a pyrimidine-2, 4-diamine template T Mohamed, JCK Yeung, MS Vasefi, MA Beazely, PPN Rao Bioorganic & medicinal chemistry letters 22 (14), 4707-4712, 2012 | 70 | 2012 |
| Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: towards non-invasive glaucoma gene therapy S Alqawlaq, JM Sivak, JT Huzil, MV Ivanova, JG Flanagan, MA Beazely, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (8), 1637-1647, 2014 | 65 | 2014 |
| D2‐class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet‐derived growth factor receptor‐dependent MA Beazely, A Tong, WL Wei, H Van Tol, B Sidhu, JF MacDonald Journal of neurochemistry 98 (5), 1657-1663, 2006 | 60 | 2006 |
| Platelet-derived growth factor-mediated induction of the synaptic plasticity gene Arc/Arg3. 1 F Peng, H Yao, X Bai, X Zhu, BC Reiner, M Beazely, K Funa, H Xiong, ... Journal of Biological Chemistry 285 (28), 21615-21624, 2010 | 58 | 2010 |
| Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons MS Vasefi, K Yang, J Li, JS Kruk, JJ Heikkila, MF Jackson, JF MacDonald, ... Molecular brain 6, 1-9, 2013 | 57 | 2013 |
| Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons MA Beazely, A Lim, H Li, C Trepanier, XM Chen, B Sidhu, JF MacDonald Journal of biological chemistry 284 (12), 8054-8063, 2009 | 55 | 2009 |
| Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells MA Beazely, JK Alan, VJ Watts Molecular pharmacology 67 (1), 250-259, 2005 | 52 | 2005 |
| Vasoactive intestinal peptide acts via multiple signal pathways to regulate hippocampal NMDA receptors and synaptic transmission K Yang, CH Trepanier, H Li, MA Beazely, EA Lerner, MF Jackson, ... Hippocampus 19 (9), 779-789, 2009 | 45 | 2009 |
| Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease G Tin, T Mohamed, N Gondora, MA Beazely, PPN Rao MedChemComm 6 (11), 1930-1941, 2015 | 42 | 2015 |
| Reactive oxygen species are required for 5-HT-induced transactivation of neuronal platelet-derived growth factor and TrkB receptors, but not for ERK1/2 activation JS Kruk, MS Vasefi, JJ Heikkila, MA Beazely PLoS One 8 (9), e77027, 2013 | 36 | 2013 |
| 5‐Hydroxytryptamine type 7 receptor neuroprotection against NMDA‐induced excitotoxicity is PDGFβ receptor dependent MS Vasefi, JS Kruk, JJ Heikkila, MA Beazely Journal of Neurochemistry 125 (1), 26-36, 2013 | 36 | 2013 |
| 5-HT7 receptor activation promotes an increase in TrkB receptor expression and phosphorylation A Samarajeewa, L Goldemann, MS Vasefi, N Ahmed, N Gondora, ... Frontiers in behavioral neuroscience 8, 391, 2014 | 33 | 2014 |
